168 related articles for article (PubMed ID: 2947636)
1. Decreased serotonin S2 and increased dopamine D2 receptors in chronic schizophrenics.
Mita T; Hanada S; Nishino N; Kuno T; Nakai H; Yamadori T; Mizoi Y; Tanaka C
Biol Psychiatry; 1986 Dec; 21(14):1407-14. PubMed ID: 2947636
[TBL] [Abstract][Full Text] [Related]
2. Alteration of dopamine receptors in the caudate nucleus and the putamen in schizophrenic brain.
Mjörndal T; Winblad B
Med Biol; 1986; 64(6):351-4. PubMed ID: 2881030
[TBL] [Abstract][Full Text] [Related]
3. Down regulation of serotonin-S2 receptor sites in rat brain by chronic treatment with the serotonin-S2 antagonists: ritanserin and setoperone.
Leysen JE; Van Gompel P; Gommeren W; Woestenborghs R; Janssen PA
Psychopharmacology (Berl); 1986; 88(4):434-44. PubMed ID: 3010361
[TBL] [Abstract][Full Text] [Related]
4. Increased brain dopamine and dopamine receptors in schizophrenia.
Mackay AV; Iversen LL; Rossor M; Spokes E; Bird E; Arregui A; Creese I; Synder SH
Arch Gen Psychiatry; 1982 Sep; 39(9):991-7. PubMed ID: 7115016
[TBL] [Abstract][Full Text] [Related]
5. Two classes of [3H]spiperone binding sites in bovine neurohypophysis: D-2 receptors and putative 5-HT2 receptors.
Treiman M; Andersen PH
J Recept Res; 1989; 9(4-5):297-312. PubMed ID: 2574236
[TBL] [Abstract][Full Text] [Related]
6. Serotonin-S2 and dopamine-D2 receptors are the same size in membranes.
Brann MR
Biochem Biophys Res Commun; 1985 Dec; 133(3):1181-6. PubMed ID: 2935151
[TBL] [Abstract][Full Text] [Related]
7. Typical and atypical antipsychotic occupancy of D2 and S2 receptors: an autoradiographic analysis in rat brain.
Altar CA; Wasley AM; Neale RF; Stone GA
Brain Res Bull; 1986 Apr; 16(4):517-25. PubMed ID: 2872945
[TBL] [Abstract][Full Text] [Related]
8. Computer imaging and analysis of dopamine (D2) and serotonin (S2) binding sites in rat basal ganglia or neocortex labeled by [3H]spiroperidol.
Altar CA; Kim H; Marshall JF
J Pharmacol Exp Ther; 1985 May; 233(2):527-38. PubMed ID: 3889277
[TBL] [Abstract][Full Text] [Related]
9. Serotonin and dopamine receptors in the rat pituitary gland: autoradiographic identification, characterization, and localization.
De Souza EB
Endocrinology; 1986 Oct; 119(4):1534-42. PubMed ID: 2944737
[TBL] [Abstract][Full Text] [Related]
10. 3H-spiperone binding sites in post-mortem brains from schizophrenic patients: relationship to neuroleptic drug treatment, abnormal movements, and positive symptoms.
Kornhuber J; Riederer P; Reynolds GP; Beckmann H; Jellinger K; Gabriel E
J Neural Transm; 1989; 75(1):1-10. PubMed ID: 2563750
[TBL] [Abstract][Full Text] [Related]
11. Increased [3H] raclopride binding sites in postmortem brains from schizophrenic violent suicide victims.
Ruiz J; Gabilondo AM; Meana JJ; García-Sevilla JA
Psychopharmacology (Berl); 1992; 109(4):410-4. PubMed ID: 1365855
[TBL] [Abstract][Full Text] [Related]
12. 3H-Flupenthixol binding in post-mortem brains of schizophrenics: evidence for a selective increase in dopamine D2 receptors.
Cross AJ; Crow TJ; Owen F
Psychopharmacology (Berl); 1981; 74(2):122-4. PubMed ID: 6791218
[TBL] [Abstract][Full Text] [Related]
13. Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics.
Wong DF; Wagner HN; Tune LE; Dannals RF; Pearlson GD; Links JM; Tamminga CA; Broussolle EP; Ravert HT; Wilson AA; Toung JK; Malat J; Williams JA; O'Tuama LA; Snyder SH; Kuhar MJ; Gjedde A
Science; 1986 Dec; 234(4783):1558-63. PubMed ID: 2878495
[TBL] [Abstract][Full Text] [Related]
14. Alterations in [3H]spiperone binding in human caudate nucleus, substantia nigra and frontal cortex in the Shy-Drager syndrome and Parkinson's disease.
Quik M; Spokes EG; Mackay AV; Bannister R
J Neurol Sci; 1979 Nov; 43(3):429-37. PubMed ID: 521836
[TBL] [Abstract][Full Text] [Related]
15. Abnormal neuroleptic/dopamine receptors in schizophrenia.
Lee T; Seeman P
Adv Biochem Psychopharmacol; 1980; 21():435-42. PubMed ID: 6103653
[TBL] [Abstract][Full Text] [Related]
16. Improvement in conditions for solubilisation and characterisation of brain D2 dopamine receptors using various detergents.
Wheatley M; Hall JM; Frankham PA; Strange PG
J Neurochem; 1984 Oct; 43(4):926-34. PubMed ID: 6470714
[TBL] [Abstract][Full Text] [Related]
17. Elevation of brain neuroleptic/dopamine receptors in schizophrenia.
Lee T; Seeman P
Am J Psychiatry; 1980 Feb; 137(2):191-7. PubMed ID: 6101525
[TBL] [Abstract][Full Text] [Related]
18. [Specific binding of 3H-domperidone--a selective ligand of D2-dopamine receptors--by the human caudate nucleus].
Zlobina GP; Chekalina ND
Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(7):1043-5. PubMed ID: 2960110
[TBL] [Abstract][Full Text] [Related]
19. Opposite regulation of serotonin-S2 and dopamine-D2 receptors in rat brain following chronic receptor blockade.
Leysen JE; Van Gompel P; de Chaffoy de Courcelles D; Niemegeers CJ
J Recept Res; 1987; 7(1-4):223-39. PubMed ID: 3625598
[TBL] [Abstract][Full Text] [Related]
20. Changes in serotonin2A and GABA(A) receptors in schizophrenia: studies on the human dorsolateral prefrontal cortex.
Dean B; Hussain T; Hayes W; Scarr E; Kitsoulis S; Hill C; Opeskin K; Copolov DL
J Neurochem; 1999 Apr; 72(4):1593-9. PubMed ID: 10098866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
